Company Data
Rallybio Corporation
Ticker
RLYB
Current Price
$0.309 -3.13%
Market Cap
$12.9M
Price Target
Refer to Report
Volume
34.7K
52wk Range
$0.2201 - $1.7291
Overview
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.